Related Experiment Video
Updated: Jul 10, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
[Variability in coronary risk assessment in HIV-infected patients]
Milagros García-Lázaro1, Antonio Rivero Román, Angela Camacho Espejo
1Sección de Enfermedades Infecciosas, Hospital Universitario Reina Sofía, Córdoba, España. milagrosglazaro@telefonica.net
Insights
Assessing coronary risk (CR) in HIV patients is crucial. The Framingham tables may overestimate CR compared to REGICOR, highlighting the need for accurate risk assessment tools in this population.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Antiretroviral treatment in HIV-infected patients may increase coronary risk (CR).
- Accurate CR assessment is vital for managing HIV patients.
- Cardiovascular disease is a growing concern in the aging HIV population.
Purpose of the Study:
- To compare the 10-year CR assessment between Framingham and REGICOR tables in HIV-infected patients.
- To evaluate the prevalence of cardiovascular risk factors in this cohort.
Main Methods:
- Prospective cohort study of 205 HIV-infected patients.
- Calculation of 10-year CR using Framingham and REGICOR adapted tables.
- Assessment of cardiovascular risk factors including smoking, dyslipidemia, hypertension, diabetes, lipodystrophy, obesity, and lifestyle.
Main Results:
- Mean age was 41.4 years; most patients were on antiretrovirals with good immunological status.
- High prevalence of current smoking (77.1%), dyslipidemia (29.3%), and sedentary lifestyle (50.7%).
- Framingham tables indicated 12.9% of patients had >10% 10-year CR, versus 2.0% with REGICOR tables (p < 0.001).
Conclusions:
- Framingham tables may overestimate coronary risk in HIV-infected patients.
- Further research is needed to determine the most appropriate CR assessment method for HIV patients.
- Caution is advised when estimating CR in HIV-infected individuals until validated methods are established.
Background And Objective:
Antiretroviral treatment of human immunodeficiency virus (HIV)-infected patients seems to increase the coronary risk (CR) in these patients. Adequate assessment of CR has significant implications for the management of these patients. Our objective was to compare 2 systems for assessing 10-year CR in HIV-infected patients.
Patients And Method:
CR was calculated in a prospective cohort of 205 HIV-infected patients using Framingham tables and REGICOR adapted tables. Prevalence of cardiovascular risk factors in these patients was evaluated.
Results:
Mean age (standard deviation) was 41.4 (8.2) years. Most patients were taking antiretrovirals and had a good immunological status. Current smoking was reported by 77.1% of patients, while a history of dyslipidemia, hypertension, or diabetes was found in 29.3%, 7.3%, and 4.9% of patients, respectively. Lipodystrophy was seen in 41% of patients, abdominal obesity in 21.5%, and a sedentary lifestyle in 50.7% Mean values obtained were 6.55 (6.36) in the Framingham scale and 2.85 (2.31) in the REGICOR scale. A 10-year CR greater than 10% was found in 26 patients (12.9%) with the Framingham tables and in 4 patients (2.0%) with the REGICOR tables. The difference between both methods was significant (p < 0.001).
Conclusions:
Application of the Framingham tables to our cohort may overestimate the CR. Studies aimed at identifying the most adequate method for measuring CR in HIV-infected patients are required. Until such data are available, estimation of CR in these patients should be taken with caution.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Relative Risk
Coronary Artery Disease II: Pathophysiology